Maravai LifeSciences Holdings, Inc. (MRVI)
| Market Cap | 384.54M |
| Revenue (ttm) | 284.10M |
| Net Income (ttm) | 88.97M |
| Shares Out | 10.35M |
| EPS (ttm) | 2.36 |
| PE Ratio | 15.74 |
| Forward PE | 41.84 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $37.15 |
| Previous Close | $35.58 |
| Change ($) | 1.57 |
| Change (%) | 4.41% |
| Day's Open | 36.12 |
| Day's Range | 35.47 - 37.64 |
| Day's Volume | 738,739 |
| 52-Week Range | 23.62 - 40.24 |
The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.
SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to part...
Maravai LifeSciences Holdings, Inc. (MRVI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Stock Market Shrugs Off J&J News; Tesla, New IPO Roblox, Vaccine Play Maravai Flash Buy Signals
Stock market rally shrugs off J&J news; Tesla, new IPO Roblox, vaccine play Maravai flash buy signals. Investor's Business Daily has been helping people invest smarter results by providing exclusive sto...
SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to...
SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators,...
SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators,...
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators,...
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai or the Company) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biot...
New integrated offering will help to meet expected increases in global demand by simplifying and accelerating production of GMP-grade mRNA product for downstream vaccine and therapeutic manufacturing Ne...
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators,...
SAN DIEGO, March 01, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to pa...
Advancement Expected to Further Accelerate Development of mRNA Vaccines and Therapeutics Advancement Expected to Further Accelerate Development of mRNA Vaccines and Therapeutics
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences , Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to...
Stocks Rebound; Qualcomm, Maravai, One Medical Clear Buy Points
Stocks rebound, Qualcomm, Maravai, One Medical clear buy points. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market...
SAN DIEGO, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today ann...
Maravai LifeSciences has received a welcome public debut. The company provides a crucial role in drug development and in fact even in the Pfizer/BioNTech vaccine.
SAN DIEGO, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech inno...
Maravai Life Sciences Holdings (NASDAQ:MRVI) will hit the public markets with perfect timing as it sees its mRNA product used by COVID-19 vaccine makers. The Offering: Maravai Life Sciences plans on sel...
About MRVI
Maravai LifeSciences is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. Our more than 5,000 customers as of September 30, 2020 include the top 20 global biopharmaceutical companies ranked by research and development expenditures according to industry consultants, and many other emerging biopharmaceutical and life sciences research companies, as well as leading academic research institutes and in vitro diagnostics companie... [Read more...]
| Industry Biotechnology | IPO Date Nov 20, 2020 |
| CEO Carl W. Hull | Employees 410 |
| Stock Exchange NASDAQ | Ticker Symbol MRVI |
Analyst Forecasts
According to 10 analysts, the average rating for MRVI stock is "Strong Buy." The 12-month stock price forecast is 48.78, which is an increase of 31.31% from the latest price.